Skip to main content

Alex Zrolka, Stan Letovsky, Kevin Sayer

Premium
Invetech has named Alex Zrolka vice president of business development for the company’s North American life sciences division, the firm said last week.
 
Zrolka previously worked in marketing management, business development, and sales for Biotech Envoy, Genicon Sciences, Qiagen, Bio-Rad Laboratories, and DNAStar.
 

 
Codon Devices has named Stan Letovsky executive director of bioinformatics and information technology, the company said last week.
 
Letovsky most recently was senior director of computational sciences at Millennium Pharmaceuticals.
 
He also was in global bioinformatics with Monsanto and worked on the Genome Database Project at Johns Hopkins Medical Institute.   
 

 
Kevin Sayer will join the board of directors at Eksigent, the company said last week.
 
Sayer, a biotech and pharmaceutical industry consultant, was named to the board as part of the company’s expansion of its medical devices segment, Eksigent said.

Filed under

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.